4th Quarter - Termination — TODD STRATEGY GROUP for CAREDX, INC. (2017)

Firm

TODD STRATEGY GROUP

Client

CAREDX, INC.

Income

—

Expenses

—

Terminated

Dec 31, 2017

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursements for laboratory tests.

Lobbyist	Covered position, as disclosed
DANIEL M TODD	Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4302 (115th)

Medical/Disease Research/Clinical Labs MED

FDA regulation of laboratory developed tests.

Lobbyist	Covered position, as disclosed
DANIEL M TODD	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.